These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 17136689)

  • 1. Prevalence, severity and predictors of HOMA-estimated insulin resistance in diabetic and nondiabetic patients with end-stage renal disease.
    Bodlaj G; Berg J; Pichler R; Biesenbach G
    J Nephrol; 2006; 19(5):607-12. PubMed ID: 17136689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
    Fragoso A; Mendes F; Silva AP; Neves PL
    J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
    Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
    Meis SB; Schuster D; Gaillard T; Osei K
    Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes.
    Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Piccinni MN; Peros E; Geroldi D; Fogari E; D'Angelo A
    Endothelium; 2007; 14(1):45-51. PubMed ID: 17364896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD.
    Biesenbach G; Bodlaj G; Ebner S; Biesenbach P; Pieringer H
    Int Urol Nephrol; 2011 Dec; 43(4):1155-60. PubMed ID: 20640938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance at different stages of diabetic kidney disease in India.
    Viswanathan V; Tilak P; Meerza R; Kumpatla S
    J Assoc Physicians India; 2010 Oct; 58():612-5. PubMed ID: 21510112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients.
    Taniguchi A; Fukushima M; Sakai M; Miwa K; Makita T; Nagata I; Nagasaka S; Doi K; Okumura T; Fukuda A; Kishimoto H; Fukuda T; Nakaishi S; Tokuyama K; Nakai Y
    Diabetes Care; 2000 Dec; 23(12):1766-9. PubMed ID: 11128349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?
    Bahceci M; Tuzcu A; Ogun C; Canoruc N; Iltimur K; Aslan C
    J Endocrinol Invest; 2005 Feb; 28(2):145-50. PubMed ID: 15887860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-Diabetics with Hypovitaminosis D Have Higher Risk for Insulin Resistance.
    Nur-Eke R; Özen M; Çekin AH
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting plasma glucose is a stronger predictor of diabetes than triglyceride-glucose index, triglycerides/high-density lipoprotein cholesterol, and homeostasis model assessment of insulin resistance: Tehran Lipid and Glucose Study.
    Tohidi M; Baghbani-Oskouei A; Ahanchi NS; Azizi F; Hadaegh F
    Acta Diabetol; 2018 Oct; 55(10):1067-1074. PubMed ID: 30066042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients.
    Covic AM; Schelling JR; Constantiner M; Iyengar SK; Sedor JR
    Kidney Int; 2000 Oct; 58(4):1742-50. PubMed ID: 11012908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of lipids, apoproteins and associated enzyme activities between diabetic and nondiabetic end-stage renal disease.
    Sakurai T; Oka T; Hasegawa H; Igaki N; Miki S; Goto T
    Nephron; 1992; 61(4):409-14. PubMed ID: 1501737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.
    Emoto M; Nishizawa Y; Maekawa K; Hiura Y; Kanda H; Kawagishi T; Shoji T; Okuno Y; Morii H
    Diabetes Care; 1999 May; 22(5):818-22. PubMed ID: 10332688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy.
    Khan S; Qayyum S; Khan MNA
    J Pak Med Assoc; 2024 May; 74(5):862-867. PubMed ID: 38783431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
    Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hemodialysis on incretin hormones and insulin secretion in diabetic and non-diabetic patients.
    Masajtis-Zagajewska A; Kurnatowska I; Wajdlich M; Jagodzińska M; Nowicki M
    Int Urol Nephrol; 2013 Dec; 45(6):1733-40. PubMed ID: 23670285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects.
    Esteghamati A; Khalilzadeh O; Abbasi M; Nakhjavani M; Novin L; Esteghamati AR
    Clin Exp Hypertens; 2008 Jul; 30(5):297-307. PubMed ID: 18633753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity.
    Nakhjavani M; Karimi-Jafari H; Esteghamati A; Khalilzadeh O; Asgarani F; Ghadiri-Anari A
    Ann Endocrinol (Paris); 2010 Sep; 71(4):303-8. PubMed ID: 20434720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.